Marek Cmero

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 5

Top Topics

Mitochondrial Dna

Immune Response

Endometrial Cancer

Top Venues

Nature communications

Prostate cancer and prostatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Marek Cmero, Ke Yuan, Cheng Soon Ong, Jan Schröder, null null, Niall M Corcoran, Anthony T Papenfuss, Christopher M Hovens, Florian Markowetz, Geoffrey Macintyre, null null
Author Correction: Inferring structural variant cancer cell fraction. Nature communications 13 (1) (2022)
Patrick McCoy, Stefano Mangiola, Geoff Macintyre, Ryan Hutchinson, Ben Tran, Bernard J Pope, Peter Georgeson, Matthew K H Hong, Natalie Kurganovs, Sebastian Lunke, Michael J Clarkson, Marek Cmero, Michael Kerger, Ryan Stuchbery, Ken Chow, Izhak Haviv, Andrew Ryan, Anthony J Costello, Niall M Corcoran, Christopher M Hovens
MSH2-deficient prostate tumours have a distinct immune response and clinical outcome compared to MSH2-deficient colorectal or endometrial cancer. Prostate cancer and prostatic diseases 24 (4) (2021)
Marek Cmero, Ke Yuan, Cheng Soon Ong, Jan Schröder, null null, Niall M Corcoran, Anthony T Papenfuss, Christopher M Hovens, Florian Markowetz, Geoffrey Macintyre, null null
Inferring structural variant cancer cell fraction. Nature communications 11 (1) (2020)
Marek Cmero, Nadia M Davidson, Alicia Oshlack
Using equivalence class counts for fast and accurate testing of differential transcript usage. F1000Research 8 (2019)
Marek Cmero, Nadia M Davidson, Alicia Oshlack
Fast and accurate differential transcript usage by testing equivalence class counts. F1000Research (2019)